1. Home
  2. MCS vs YDES Comparison

MCS vs YDES Comparison

Compare MCS & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marcus Corporation (The)

MCS

Marcus Corporation (The)

HOLD

Current Price

$19.40

Market Cap

590.8M

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$5.12

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MCS
YDES
Founded
1935
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Movies/Entertainment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
590.8M
543.0M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MCS
YDES
Price
$19.40
$5.12
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$23.33
N/A
AVG Volume (30 Days)
121.0K
28.5K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
1.66%
N/A
EPS Growth
N/A
N/A
EPS
0.77
N/A
Revenue
$758,458,000.00
N/A
Revenue This Year
$12.05
N/A
Revenue Next Year
$3.15
N/A
P/E Ratio
$25.74
N/A
Revenue Growth
3.11
N/A
52 Week Low
$12.85
$5.00
52 Week High
$20.02
$25.00

Technical Indicators

Market Signals
Indicator
MCS
YDES
Relative Strength Index (RSI) 64.57 31.56
Support Level $14.66 N/A
Resistance Level N/A $9.11
Average True Range (ATR) 0.59 0.70
MACD 0.09 -0.09
Stochastic Oscillator 78.22 2.00

Price Performance

Historical Comparison
MCS
YDES

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: